“Crystalline Syndiotactic Polystyrene as Reinforcing Agent of cis-1,4-Polybutadiene Rubber”

ABSTRACT: Syndiotactic polystyrene (sPS), a thermoplastic polymer characterized by high crystallinity, good chemical resistance and high modulus, has been successfully tested as a reinforcing agent for cis-1,4- polybutadiene (PB) rubber. Blends of sPS and PB have been in situ synthesized using a multistep polymerization process catalyzed by monocyclopentadienyl titanium compounds activated with MAO. This procedure assures an intimate mixing of the components and homogeneous dispersion of the sPS particles having dimension from few hundreds of nanometers to micrometers. The analysis of the mechanical properties of the sPS-PB blends obtained using this process showed enhanced Young’s modulus, toughness, σbreak and ε break: these properties were found to be 1 order of magnitude higher than those of PB and comparable to those of PB charged with inorganic filler as carbon black or silica. A multiblock copolymer (sPSB) comprising segments of sPS and PB was successfully in situ synthesized with the sPS and PB homopolymers and found to be an active compatibilizer of these blends producing a novel semicrystalline phase at the interphase between the sPS particles and the PB matrix

Solvent- and solvothermal-induced phase transitions and crystallisations in syndiotactic polystyrene and multiblock copolymer syndiotactic polystyrene-co-cis-1,4-polybutadiene

The complex polymorphism of nanoporous syndiotactic polystyrene never stops to amaze. Simple and rapid solvent- and solvothermal-induced crystallisation of syndiotactic polystyrene (sPS) and syndiotactic polystyrene polymer segments in the multiblock copolymer syndiotactic polystyrene-co-cis-1,4-polybutadiene (sPSB) into the desired crystalline form have been disclosed and herein reported. Stirring polymer powders of sPS in the chloroform/water solvent mixture allows crystallisation of the amorphous phase and the conversion of the co-crystalline δ forms into the highly crystalline δ form; variable combinations of water with other common non-polar solvents, or of chloroform with methanol failed in this transformation. The γ form has been obtained by solvothermal treatment of the δ form by simple refluxing in acetonitrile. Stirring the γ form in chloroform/water mixture affords its rapid conversion into the ε form with elevated crystallinity. Finally, applying the chloroform/water treatment to the β form yields the δ form with high crystallinity. The complex polymorphism of the sPS was also found in sPSB copolymer, even with short styrene segments. The thermal behaviour, in terms of melting enthalpy and temperature, was investigated at the variance of styrene content

Efficient and Sustainable Treatment of Tannery Wastewater by a Sequential Electrocoagulation-UV Photolytic Process

Tannery wastewater contains large amounts of pollutants that, if directly discharged into ecosystems, can generate an environmental hazard. The present investigation has focused the attention to the remediation of wastewater originated from tanned leather in Tunisia. The analysis revealed wastewater with a high level of chemical oxygen demand (COD) of 7376 mgO2/L. The performance in reduction of COD, via electrocoagulation (EC) or UV photolysis or, finally, operating electrocoagulation and photolysis in sequence was examined. The effect of voltage and reaction time on COD reduction, as well as the phytotoxicity were determined. Treated effluents were analysed by UV spectroscopy, extracting the organic components with solvents differing in polarity. A sequential EC and UV treatment of the tannery wastewater has been proven effective in the reduction of COD. These treatments combined afforded 94.1 % of COD reduction, whereas the single EC and UV treatments afforded respectively 85.7 and 55.9 %. The final COD value of 428.7 mg/L was found largely below the limit of 1000 mg/L for admission of wastewater in public sewerage network. Germination tests of Hordeum Vulgare seeds indicated reduced toxicity for the remediated water. Energy consumptions of 33.33 kWh/m3 and 314.28 kWh/m3 were determined for the EC process and for the same followed by UV treatment. Both those technologies are yet available and ready for scale-up

A djuvant treatment in patients at high risk of recurrence of thymoma: Efficacy and safety of a three-dimensional conformal radiation therapy regimen

The clinical benefits of postoperative radiation therapy (PORT) for patients with thymoma are still controversial. In the absence of defined guidelines, prognostic factors such as stage, status of surgical margins, and histology are often considered to guide the choice of adjuvant treatment (radiotherapy and/or chemotherapy). In this study, we describe our single-institution experience of three-dimensional conformal PORT administered as adjuvant treatment to patients with thymoma. METHODS: Twenty-two consecutive thymoma patients (eleven male and eleven female) with a median age of 52 years and treated at our institution by PORT were analyzed. The patients were considered at high risk of recurrence, having at least one of the following features: stage IIB or III, involved resection margins, or thymic carcinoma histology. Three-dimensional conformal PORT with a median total dose on clinical target volume of 50 (range 44-60) Gy was delivered to the tumor bed by 6-20 MV X-ray of the linear accelerator. Follow-up after radiotherapy was done by computed tomography scan every 6 months for 2 years and yearly thereafter. RESULTS: Two of the 22 patients developed local recurrence and four developed distant metastases. Median overall survival was 100 months, and the 3-year and 5-year survival rates were 83% and 74%, respectively. Median disease-free survival was 90 months, and the 5-year recurrence rate was 32%. On univariate analysis, pathologic stage III and presence of positive surgical margins had a significant impact on patient prognosis. Radiation toxicity was mild in most patients and no severe toxicity was registered. CONCLUSION: Adjuvant radiotherapy achieved good local control and showed an acceptable toxicity profile in patients with high-risk thymoma

A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review

Primary urethral carcinoma (PUC) is a rare and aggressive cancer, often underdetected and consequently unsatisfactorily treated. We report a case of advanced PUC, surgically treated with combined approaches. A 47-year-old man underwent transurethral resection of a urethral lesion with histological evidence of a poorly differentiated squamous cancer of the bulbomembranous urethra. Computed tomography (CT) and bone scans excluded metastatic spread of the disease but showed involvement of both corpora cavernosa (cT3N0M0). A radical surgical approach was advised, but the patient refused this and opted for chemotherapy. After 17 months the patient was referred to our department due to the evidence of a fistula in the scrotal area. CT scan showed bilateral metastatic disease in the inguinal, external iliac, and obturator lymph nodes as well as the involvement of both corpora cavernosa. Additionally, a fistula originating from the right corpus cavernosum extended to the scrotal skin. At this stage, the patient accepted the surgical treatment, consisting of different phases. Phase I: Radical extraperitoneal cystoprostatectomy with iliac-obturator lymph nodes dissection. Phase II: Creation of a urinary diversion through a Bricker ileal conduit. Phase III: Repositioning of the patient in lithotomic position for an overturned Y skin incision, total penectomy, fistula excision, and "en bloc" removal of surgical specimens including the bladder, through the perineal breach. Phase IV: Right inguinal lymphadenectomy. The procedure lasted 9-and-a-half hours, was complication-free, and intraoperative blood loss was 600 mL. The patient was discharged 8 days after surgery. Pathological examination documented a T4N2M0 tumor. The clinical situation was stable during the first 3 months postoperatively but then metastatic spread occurred, not responsive to adjuvant chemotherapy, which led to the patient's death 6 months after surgery. Patients with advanced stage tumors of the bulbomembranous urethra should be managed with radical surgery including the corporas up to the ischiatic tuberosity attachment, and membranous urethra in continuity with the prostate and bladder. Neo-adjuvant treatment may be advisable with the aim of improving the poor prognosis, even if the efficacy is not certain while it can delay the radical treatment of the disease

First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings

Although both docetaxel and androgen-receptor-axis-targeted (ARAT) agents have yielded survival improvements in combination with androgen deprivation therapy (ADT) compared to ADT alone in metastatic castration-sensitive prostate cancer (mCSPC) patients, the optimal therapeutic choice remains to be established. We analyzed estimates of the hazard ratios for death (OS-HRs) in patients treated in the first-line setting enrolled in the GETUG-AFU15, CHAARTED, STAMPEDE, LATITUDE, ENZAMET, and TITAN trials. Overall, men with mCSPC receiving ADT with vs. without either an ARAT agent or docetaxel as first-line systemic therapy showed a pooled OS-HR of 0.69 (95 % CI: 0.61-0.78), with significant heterogeneity (p = 0.045, I2 = 52.5 %). Network meta-analysis showed an OS-HR in patients receiving an ARAT agent vs. docetaxel of 0.78 (95 %CI: 0.67-0.91). In conclusion, the evidence analysed indicates that an ARAT agent may provide improved OS outcomes compared to docetaxel. Prospective randomized trials are warranted

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis

Three or four cycles of cisplatin-based chemotherapy is the standard neoadjuvant treatment prior to cystectomy in patients with muscle-invasive bladder cancer. Although NCCN guidelines recommend 4 cycles of cisplatin-gemcitabine, three cycles are also commonly administered in clinical practice. In this multicenter retrospective study, we assessed a large and homogenous cohort of patients with urothelial bladder cancer (UBC) treated with three or four cycles of neoadjuvant cisplatin-gemcitabine followed by radical cystectomy, in order to explore whether three vs. four cycles were associated with different outcomes

Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy

To investigate the prognostic role of neutrophil percentage-to-albumin ratio (NPAR) in muscle-invasive bladder cancer (MIBC) patients treated with neoadjuvant chemotherapy (NAC) and radical cystectomy (RC)

The IASLC/ITMIG thymic epithelial tumors staging project: Proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors

Despite longstanding recognition of thymic epithelial neoplasms, there is no official American Joint Committee on Cancer/ Union for International Cancer Control stage classification. This article summarizes proposals for classification of the T component of stage classification for use in the 8th edition of the tumor, node, metastasis classification for malignant tumors. This represents the output of the International Association for the Study of Lung Cancer and the International Thymic Malignancies Interest Group Staging and Prognostics Factor Committee, which assembled and analyzed a worldwide database of 10,808 patients with thymic malignancies from 105 sites. The committee proposes division of the T component into four categories, representing levels of invasion. T1 includes tumors localized to the thymus and anterior mediastinal fat, regardless of capsular invasion, up to and including infiltration through the mediastinal pleura. Invasion of the pericardium is designated as T2. T3 includes tumors with direct involvement of a group of mediastinal structures either singly or in combination: lung, brachiocephalic vein, superior vena cava, chest wall, and phrenic nerve. Invasion of more central structures constitutes T4: aorta and arch vessels, intrapericardial pulmonary artery, myocardium, trachea, and esophagus. Size did not emerge as a useful descriptor for stage classification. This classification of T categories, combined with a classification of N and M categories, provides a basis for a robust tumor, node, metastasis classification system for the 8th edition of American Joint Committee on Cancer/Union for International Cancer Control stage classification